Lindbrook Capital’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-28
Closed -$2.17K 2863
2023
Q2
$2.17K Buy
28
+12
+75% +$931 ﹤0.01% 2123
2023
Q1
$1.46K Buy
+16
New +$1.46K ﹤0.01% 2368
2022
Q4
Sell
-17
Closed -$3K 3061
2022
Q3
$3K Buy
+17
New +$3K ﹤0.01% 1953
2022
Q2
Sell
-12
Closed -$2K 2844
2022
Q1
$2K Buy
+12
New +$2K ﹤0.01% 2115